Dr Maria Alsina speaks to ecancer at ESMO 2019 in Barcelona about molecular subtypes of metastatic gastric cancer.

Dr Alsina explains that the study aimed to classify the patients in a simpler way, as it recognised that some platforms cannot be applied in clinics.

Dr Alsina discusses the findings of the study so far, but concludes that a larger cohort of patients is needed to validate their findings.